![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Department of Genetics, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.
Abstract
Neuraminidases (sialidases) have an essential role in the removal of terminal sialic acid residues from sialoglycoconjugates and are distributed widely in nature. The human lysosomal enzyme occurs in complex with beta-galactosidase and protective protein/cathepsin A (PPCA), and is deficient in two genetic disorders: sialidosis, caused by a structural defect in the neuraminidase gene, and galactosialidosis, in which the loss of neuraminidase activity is secondary to a deficiency of PPCA. We identified a full-length cDNA clone in the dbEST data base, of which the predicted amino acid sequence has extensive homology to other mammalian and bacterial neuraminidases, including the F(Y)RIP domain and "Asp-boxes." In situ hybridization localized the human neuraminidase gene to chromosome band 6p21, a region known to contain the HLA locus. Transient expression of the cDNA in deficient human fibroblasts showed that the enzyme is compartmentalized in lysosomes and restored neuraminidase activity in a PPCA-dependent manner. The authenticity of the cDNA was verified by the identification of three independent mutations in the open reading frame of the mRNA from clinically distinct sialidosis patients. Coexpression of the mutant cDNAs with PPCA failed to generate neuraminidase activity, confirming the inactivating effect of the mutations. These results establish the molecular basis of sialidosis in these patients, and clearly identify the cDNA-encoded protein as lysosomal neuraminidase.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  T. Miyagi, T. Wada, K. Yamaguchi, K. Hata, and K. Shiozaki Plasma Membrane-associated Sialidase as a Crucial Regulator of Transmembrane Signalling J. Biochem., September 1, 2008; 144(3): 279 - 285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Santamaria, A. Chabas, J. W. Callahan, D. Grinberg, and L. Vilageliu Expression and characterization of 14 GLB1 mutant alleles found in GM1-gangliosidosis and Morquio B patients J. Lipid Res., October 1, 2007; 48(10): 2275 - 2282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Liang, V. Seyrantepe, K. Landry, R. Ahmad, A. Ahmad, N. M. Stamatos, and A. V. Pshezhetsky Monocyte Differentiation Up-regulates the Expression of the Lysosomal Sialidase, Neu1, and Triggers Its Targeting to the Plasma Membrane via Major Histocompatibility Complex Class II-positive Compartments J. Biol. Chem., September 15, 2006; 281(37): 27526 - 27538. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Hinek, A. V. Pshezhetsky, M. von Itzstein, and B. Starcher Lysosomal Sialidase (Neuraminidase-1) Is Targeted to the Cell Surface in a Multiprotein Complex That Facilitates Elastic Fiber Assembly J. Biol. Chem., February 10, 2006; 281(6): 3698 - 3710. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Seyrantepe, K. Landry, S. Trudel, J. A. Hassan, C. R. Morales, and A. V. Pshezhetsky Neu4, a Novel Human Lysosomal Lumen Sialidase, Confers Normal Phenotype to Sialidosis and Galactosialidosis Cells J. Biol. Chem., August 27, 2004; 279(35): 37021 - 37029. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Tringali, N. Papini, P. Fusi, G. Croci, G. Borsani, A. Preti, P. Tortora, G. Tettamanti, B. Venerando, and E. Monti Properties of Recombinant Human Cytosolic Sialidase HsNEU2: THE ENZYME HYDROLYZES MONOMERICALLY DISPERSED GM1 GANGLIOSIDE MOLECULES J. Biol. Chem., January 30, 2004; 279(5): 3169 - 3179. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Kakugawa, T. Wada, K. Yamaguchi, H. Yamanami, K. Ouchi, I. Sato, and T. Miyagi Up-regulation of plasma membrane-associated ganglioside sialidase (Neu3) in human colon cancer and its involvement in apoptosis suppression PNAS, August 6, 2002; 99(16): 10718 - 10723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. de Geest, E. Bonten, L. Mann, J. de Sousa-Hitzler, C. Hahn, and A. d'Azzo Systemic and neurologic abnormalities distinguish the lysosomal disorders sialidosis and galactosialidosis in mice Hum. Mol. Genet., June 1, 2002; 11(12): 1455 - 1464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Lukong, V. Seyrantepe, K. Landry, S. Trudel, A. Ahmad, W. A. Gahl, S. Lefrancois, C. R. Morales, and A. V. Pshezhetsky Intracellular Distribution of Lysosomal Sialidase Is Controlled by the Internalization Signal in Its Cytoplasmic Tail J. Biol. Chem., November 30, 2001; 276(49): 46172 - 46181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Erik. J. Bonten, W. F. Arts, M. Beck, A. Covanis, M. A. Donati, R. Parini, E. Zammarchi, and A. d'Azzo Novel mutations in lysosomal neuraminidase identify functional domains and determine clinical severity in sialidosis Hum. Mol. Genet., November 1, 2000; 9(18): 2715 - 2725. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. C. Luedtke, S. Andonian, S. Igdoura, and L. Hermo Cathepsin A Is Expressed in a Cell- and Region-specific Manner in the Testis and Epididymis and Is Not Regulated by Testicular or Pituitary Factors J. Histochem. Cytochem., August 1, 2000; 48(8): 1131 - 1146. [Abstract] [Full Text]
|
|
|
|
|
|
K. E. Lukong, M.-A. Elsliger, Y. Chang, C. Richard, G. Thomas, W. Carey, A. Tylki-Szymanska, B. Czartoryska, T. Buchholz, G. R. Criado, et al. Characterization of the sialidase molecular defects in sialidosis patients suggests the structural organization of the lysosomal multienzyme complex Hum. Mol. Genet., April 12, 2000; 9(7): 1075 - 1085. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Hasegawa, K. Yamaguchi, T. Wada, A. Takeda, Y. Itoyama, and T. Miyagi Molecular Cloning of Mouse Ganglioside Sialidase and Its Increased Expression in Neuro2a Cell Differentiation J. Biol. Chem., March 10, 2000; 275(11): 8007 - 8015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Monti, A. Preti, C. Nesti, A. Ballabio, and G. Borsani Expression of a novel human sialidaseencoded by the NEU2 gene Glycobiology, December 1, 1999; 9(12): 1313 - 1321. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Katoh, T. Miyagi, H. Taniguchi, Y.-i. Matsubara, J.-i. Kadota, A. Tominaga, P. W. Kincade, S. Matsukura, and S. Kohno Cutting Edge: An Inducible Sialidase Regulates the Hyaluronic Acid Binding Ability of CD44-Bearing Human Monocytes J. Immunol., May 1, 1999; 162(9): 5058 - 5061. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Miyagi, T. Wada, A. Iwamatsu, K. Hata, Y. Yoshikawa, S. Tokuyama, and M. Sawada Molecular Cloning and Characterization of a Plasma Membrane-associated Sialidase Specific for Gangliosides J. Biol. Chem., February 19, 1999; 274(8): 5004 - 5011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Rudenko, E. Bonten, Wim. G. J. Hol, and A. d'Azzo The atomic model of the human protective protein/cathepsin A suggests a structural basis for galactosialidosis PNAS, January 20, 1998; 95(2): 621 - 625. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Bonten and A. d'Azzo Lysosomal Neuraminidase. CATALYTIC ACTIVATION IN INSECT CELLS IS CONTROLLED BY THE PROTECTIVE PROTEIN/CATHEPSIN A J. Biol. Chem., November 22, 2000; 275(48): 37657 - 37663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Lukong, K. Landry, M.-A. Elsliger, Y. Chang, S. Lefrancois, C. R. Morales, and A. V. Pshezhetsky Mutations in Sialidosis Impair Sialidase Binding to the Lysosomal Multienzyme Complex J. Biol. Chem., May 11, 2001; 276(20): 17286 - 17290. [Abstract] [Full Text] [PDF]
|
|
